专题:Systemic Lupus Erythematosus Research

This cluster of papers focuses on the systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS), covering topics such as classification criteria, autoantibody development, interferon-inducible genes, nephritis, B lymphocyte depletion therapy, thrombosis risk, immunopathogenesis, toll-like receptors, and the epidemiology of autoimmune diseases. The research aims to improve understanding, diagnosis, classification, and management of SLE and APS.
最新文献
Unmet Needs in the Care of Systemic Lupus Erythematosus

article Full Text OpenAlex

Barriers and Facilitators Associated With Delays in the Diagnosis and Treatment of Lupus: Insights From Patients and Rheumatologists From the Andean/Bolivarian Region

article Full Text OpenAlex

Multi-omics-driven biomarker discovery in autoimmune diseases: a comprehensive review

article Full Text OpenAlex

Autoantibody-triggered podocyte membrane budding drives autoimmune kidney disease

article Full Text OpenAlex

Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activity

article Full Text OpenAlex

Emerging AI- and Biomarker-Driven Precision Medicine in Autoimmune Rheumatic Diseases: From Diagnostics to Therapeutic Decision-Making

article Full Text OpenAlex

Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus

article Full Text OpenAlex

Immunopathogenesis of Systemic Lupus Erythematosus: Interplay of Innate and Adaptive Immunity, Microbiome Dysbiosis, and Emerging Therapeutic Targets

review Full Text OpenAlex

A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy

article Full Text OpenAlex

Barriers and Facilitators Associated With Delays in the Diagnosis and Treatment of Lupus: A Qualitative Study of Patients and Rheumatologists in the Central American and Caribbean Region

article Full Text OpenAlex

近5年高被引文献
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

article Full Text OpenAlex 1611 FWCI232.0692

Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria

review Full Text OpenAlex 1013 FWCI260.7898

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

article Full Text OpenAlex 791 FWCI253.6348

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

article Full Text OpenAlex 790 FWCI199.4643

Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK

article Full Text OpenAlex 714 FWCI184.8201

Global epidemiology of rheumatoid arthritis

review Full Text OpenAlex 685 FWCI112.0334

Rheumatoid arthritis

article Full Text OpenAlex 625 FWCI157.8041

The pathogenesis of rheumatoid arthritis

review Full Text OpenAlex 616 FWCI70.1486

Rheumatoid Arthritis — Common Origins, Divergent Mechanisms

review Full Text OpenAlex 615 FWCI156.0367

Pathogenesis of autoimmune disease

review Full Text OpenAlex 539 FWCI89.98